CLASS II ONGOING Drug recall · Reported 11 Feb 2026 · FDA Enforcement Report

Trazodone Hydrochloride, USP, 50 mg recalled by Granules Pharmaceuticals

Granules Pharmaceuticals is recalling Trazodone Hydrochloride, USP, 50 mg, distributed nationwide in the US. The recall was initiated on 26 Jan 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesBatch # 6160008A, Exp Date: 12/31/2026
NDC70010-231, 70010-232, 70010-233, 70010-234
UPC0370010232013, 0370010233010, 0370010231016, 0370010234017
Quantity recalled71424 bottles.

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0305-2026
FDA event ID
98345
Recalling firm
Granules Pharmaceuticals, Chantilly, VA
Manufacturer
Granules Pharmaceuticals Inc.
Classification
Class II
Status
Ongoing
Recall initiated
26 Jan 2026
FDA classified
11 Feb 2026
Reported
11 Feb 2026
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Other Reasons
Drug class
Antidepressants

Timeline

26 Jan 2026Recall initiated by company
11 Feb 2026Classified by FDA+16 days
11 Feb 2026Published in enforcement report+0 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Tablets/Capsules

Product as listed by the FDA

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.

Where it was distributed

US Nationwide.

Nationwide

Questions about this recall

Why was it recalled?

Presence of Foreign Tablets/Capsules

Which lots are affected?

Batch # 6160008A, Exp Date: 12/31/2026

Where was it sold?

US Nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Granules Pharmaceuticals

All 11
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIDextroamphetamine Saccharate recalled by Granules PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateGranules PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIDextroamphetamine Saccharate recalled by Granules PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateGranules PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIDextroamphetamine Saccharate recalled by Granules PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateGranules PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIDextroamphetamine Saccharate recalled by Granules PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateGranules PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIDextroamphetamine Saccharate recalled by Granules PharmaceuticalsDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine SulfateGranules PharmaceuticalsPotency & AssayNationwide

Other Trazodone recalls

All 8